Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
- Soaring Overdose Rates in the Pandemic Reflected Widening Racial Disparities
- Rutgers Will Conduct the Most Comprehensive Study Ever Done of High-Risk Children Newly Diagnosed With Type 1 Diabetes.
- A U.S.-Russia nuclear war could starve 5 billion to death, study says.
- ‘All of us are living with trauma’
- Association of Clinical and Translational Science Development Roundtable, September 21